In March, Spineart USA revenues reached a new record by exceeding for the first time the symbolic $2.5 millions mark; during this month a record 375 US patients were treated with Spineart implants.
Overall, very good sales performances worldwide in Q1 2019 with an outstanding growth in the US of +34,9% versus Q1 2018, +14,7% in EU direct and +8,1% Rest Of the World.
Congratulations to the US team, to the sales team worldwide and to the “shadow workers” who serve and support them on a daily basis and allow them to focus on expanding Spineart’s footprint in the spine market.